B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation

Immunity

Volumn 6, Issue 3, 1997, Pages 303-313

  Borriello, Frank ^a   Sethna, Michael P ^e   Boyd, Scott D ^e   Schweitzer, A Nicola ^e   Tivol, Elizabeth A ^e   Jacoby, Douglas ^e   Strom, Terry B ^b   Simpson, Elizabeth M ^c   Freeman, Gordon J ^d   Sharpe, Arlene H ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c JACKSON LABORATORY   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOLOGICAL ADJUVANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; GERMINAL CENTER; HUMORAL IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030936275     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80333-7     Document Type: Article

References (59)

1. Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J.H., Lanier, L.L., and Somoza, C. (1993). B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366, 76-79.
2. Boom, W.H., Liano, D., and Abbas, A.K. (1988). Heterogeneity of helper/inducer T lymphocytes. II. Effects of IL-4 and IL-2 producing T cell clones on resting B lymphocytes. J. Exp. Med. 167, 1350-1363.
3. Borriello, F., Oliveros, J., Freeman, G.J., Nadler, L.M., and Sharpe, A.H. (1995). Differential expression of alternate mB7-2 transcripts. J. Immunol. 155, 5490-5497.
4. Boussiotis, V.A., Freeman, G.J., Gribben, J.G., Daley, J., Gray, G., and Nadler, L.M. (1993). Activated human B lymphocytes express three CTLA-4 binding counter-receptors which costimulate T cell activation. Proc. Natl. Acad. Sci. USA 90, 11059-11063.
5. Brett, S.J., Dunlop, L., Liew, F.Y., and Tite, J.P. (1993). Influence of the antigen delivery system on immunoglobulin isotype selection and cytokine production in response to influenza A nucleoprotein. Immunology 80, 306-312.
6. Burstein, H.J., Tepper, R.I., Leder, P., and Abbas, A.K. (1991). Humoral immune functions in IL-4 transgenic mice. J. Immunol. 147, 2950-2956.
7. Claassen, E., and Van Rooijen, N. (1984). TNP-enzyme conjugates for the detection of anti-TNP antibody producing cells in vivo. J. Immunol. Meth. 75, 181-188.
8. Cross, A.H., Girard, T.J., Giacoletto, K.S., Evans, R.J., Keeling, R.M., Lin, R.F., Trotter, J.L., and Karr, R.W. (1995). Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. J. Clin. Invest. 95, 2783-2789.
9. de Boer, M., Kasran, A., Kwekkeboom, J., Walter, H., Vandenberghe, P., and Ceuppens, J.L. (1993). Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells. Eur. J. Immunol. 23, 3120-3125.
10. Ferguson, S.E., Han, S.H., Kelsoe, G., and Thompson, C.B. (1996). CD28 is required for germinal center formation. J. Immunol. 156, 4576-4581.
11. Finck, B., Linsley, P., and Wofsy, D. (1994). Treatment of murine lupus with CTLA-4Ig. Science 265, 1225-1227.
12. Freedman, A.S., Freeman, G.J., Horowitz, J.C., Daley, J., and Nadler, L.M. (1987). B7, a B cell restricted antigen which identifies pre-activated B cells. J. Immunol. 137, 3260-3267.
13. Freedman, A.S., Freeman, G.J., Rhynhart, K., and Nadler, L.M. (1991). Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: a potential mechanism for amplification of T cell activation. Cell. Immunol. 137, 429-437.
14. Freeman, G.J., Freedman, A.S., Segil, J.M., Lee, G., Whitman, J.F., and Nadler, L.M. (1989). B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143, 2714-2722.
15. Freeman, G.J., Gray, G.S., Gimmi, C.D., Lombard, D.B., Zhou, L.J., White, M., Fingeroth, J.D., Gribben, J.G., and Nadler, L.M. (1991). Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J. Exp. Med. 174, 625-631.
16. Freeman, G.J., Borriello, F., Hodes, R.J., Reiser, H., Hathcock, K.S., Laszlo, G., McKnight, AJ., Kim, J.L.D., Lombard, D.B., Gray, G.S., Nadler, L.M., and Sharpe, A.H. (1993a). Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262, 907-909.
17. Freeman, G.J., Borriello, F., Hodes, R.J., Reiser, H., Gribben, J.J., Ng, J.W., Kim, J., Goldberg, J.M., Hathcock, K.G.L., Lombard, L.A., Wang, S., Gray, G., Nadler, L.M., and Sharpe, A.H. (1993b). Murine B7-2, an alternative CTLA-4 counter-receptor that costimulates T cell proliferation and interleukin-2 production. J. Exp. Med. 178, 2185-2192.
18. Freeman, G.J., Gribben, J.G., Boussiotis, V.A., Ng, J.W., Restivo, V., Lombard, L., Gray, G.S., and Nadler, L.M. (1993c). Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262, 909-911.
19. Freeman, G.J., Boussiotis, V.A., Anumanthan, A., Bernstein, G.M., Ke, X.Y., Rennert, P.D., Gray, G.S., Gribben, J.G., and Nadler, L.M. (1995). B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2, 523-532.
20. Gajewski, T.F. (1996). B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro. J. Immunol. 756, 465-472.
21. Gribben, J.G., Freeman, G.J., Boussiotis, V.A., Rennert, P., Jellis, C.L., Greenfield, E., Barber, M., Gray, G.S., and Nadler, L.M. (1994). CTLA-4 mediated costimulation induces apoptosis of activated human T lymphocytes. Proc. Natl. Acad. Sci. USA 92, 811-815.
22. Gritz, L., and Davies, J. (1993). Plasmid-encoded hygromycin B resistance: the sequence of the hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. Gene 25, 179-188.
23. Man, S., Hathcock, K., Zheng, B., Kepler, T.B., Hodes, R., and Kelsoe, G. (1995). Cellular interaction in germinal centers: roles of CD40 ligand and B7-2 in established germinal centers. J. Immunol. 155, 556-567.
24. Harper, K., Balzano, C., Rouvier, E., Mattel, M.G., Luciani, M.F., and Golstein, P. (1991). CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 147, 1037-1044.
25. Hathcock, K.S., Laszlo, G., Dickler, H.B., Bradshaw, J., Linsley, P., and Hodes, R.J. (1993). Identification of a novel CTLA-4 ligand that is costimulatory for T cell activation. Science 262, 905-907.
26. Heinzel, F., Sadick, M., Holaday, B., Coffman, R.L., and Locksley, R.M. (1989). Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169, 59-72.
27. Inaba, K., Witmerpack, M., Inaba, M., Hathcock, K.S., Sakuta, H., Azuma, M., Yagita, H., Okumura, K., Linsley, P.S., Ikehara, S., Muramatsu, S., Hodes, R.J., and Steinman, R.M. (1994). The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180, 1849-1860.
28. Johnson, K.A., Lerner, C.P., Di Lacio, L.C., Laird, P.W., Sharpe, A.H., and Simpson, E.A. (1995). Transgenic mice for the preparation of hygromycin-resistant primary embryonic fibroblast feeder layers for embryonic stem cell selections. Nucl. Acids Res. 23, 1273-1275.
29. June, C.H., Bluestone, J.A., Nadler, L.M., and Thompson, C.B. (1994). The B7 and CD28 receptor families, Immunol. Today 15, 321-331.
30. Kaster, K.R., Burgett, S.G., Rao, R.N., and Ingolia, T.D. (1993). Analysis of a bacterial hygromycin B resistance gene by transcriptional and translational fusions and by DNA sequencing. Nucl. Acids Res. 11, 6895-6911.
31. Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., and Kikutani, H. (1994). The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167-178.
32. Kearney, E., Pape, K., Loh, D., and Jenkins, M. (1994). Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1, 327-339.
33. Krummel, M., and Allison, J.P. (1995). CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459-466.
34. Lanier, L.L., Ofallon, S., Somoza, C., Phillips, J.H., Linsley, P., Okumura, K., Ito, D., and Azuma, M. (1995). CD80 (B7) and CD86(B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154, 97-105.
35. Larsen, C.P., Ritchie, S.C., Hendrix, R., Linsley, P.S., Hathcock, K.S., Hodes, R.J., Lowry, R.P., and Pearson, T.C. (1994). Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152, 5208-5219.
36. Lenschow, D.J., Zeng, Y., Thistlethwaite, J.R., Montag, A., Brady, W., Gibson, M.G., Linsley, P.S., and Bluestone, J.A. (1992). Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA-4Ig. Science 257, 789-792.
37. Lenschow, D.J., Sperling, A.I., Cooke, M.P., Freeman, G., Rhee, L., Decker, D.C., Gray, G., Nadler, L.M., Goodnow, C.C., and Bluestone, J.A. (1994). Differential upregulation of the B7-1 and B7-2 costimulatory molecules following immunoglobulin receptor engagement by antigen. J. Immunol. 153, 1990-1997.
38. Lenschow, D.J., Ho, S.C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K.C., and Bluestone, J.A. (1995). Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181, 1145-1155.
39. Linsley, P.S., Clark, E.A., and Ledbetter, J.A. (1990). T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci. USA 87, 5031-5035.
40. Linsley, P.S., Greene, J.L., Brady, W., Bayorath, J., Ledbetter, J.A., and Peach, R. (1994). Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1, 793-801.
41. Liu, Y., and Janeway, C.A. (1991). Microbial induction of co-stimulatory activity for CD4 T cell growth. Int. Immunol. 3, 323-332.
42. Mansour, S.L., Thomas, K.R., and Capecchi, M.R. (1988). Disruption of the protooncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336, 348-352.
43. McBurney, M.W., Sutherland, L.C., Adra, C.N., Leclair, B., Rudnicki, M.A., and Jardine, K. (1991). The mouse Pgk-1 gene promoter contains an upstream activator sequence. Nucl. Acids Res. 19, 5755-5761.
44. Miller, S., and Karpus, W. (1994). The immunopathogenesis and regulation of T cell mediated demyelinating diseases. Immunol. Today 15, 356-361.
45. Peach, R.J., Bajorath, J., Naemura, J., Leytze, G., Greene, J., Aruffo, A., and Linsley, P.S. (1995). Both extracellular immunoglobulin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28. J. Biol. Chem. 270, 21181-21187.
46. Perrin, P.J., Scott, D., Quigley, L., Albert, P.S., Feder, O., Gray, G.S., Abe, R., June, C.H., and Racke, M.K. (1995). Role of B7/CD28 CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J. Immunol. 154, 1481-1490.
47. Ranheim, E.A., and Kipps, T.J. (1995). Tumor necrosis factor-α facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10 and CD40L. Cell. Immunol. 161, 226-235.
48. Reiser, H., Freeman, G.J., Razi-Wolf, Z., Gimmi, C.D., Benacerraf, B., and Nadler, L.M. (1992). Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complex. Proc. Natl. Acad. Sci. USA 89, 271-275.
49. Rose, M.L., Birbeck, M.S.C., Wallis, J.A., Forrester, J.A., and Davies, A.J.S. (1980). Peanut lectin binding properties of germinal centres of mouse lymphoid tissue. Nature 284, 364-366.
50. Roy, M., Aruffo, A., Ledbetter, J., Linsley, P., Kehry, M., and Noelle, R. (1995). Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25, 596-603.
51. Salgame, P., Abrams, J., Clayberger, C., Goldstein, H., Convit, J., Modlin, R.L., and Bloom, B.R. (1991). Differing lymphokine profiles of functional subsets of human CD4 and CD8 cell clones. Science 254, 279-282.
52. Steurer, W., Nickerson, P., Stelle, A., Zheng, X., and Strom, B. (1995). Ex vivo coating of islet cell allografts with murine CTLA-4/Fc promotes graft tolerance. J. Immunol. 155, 1165-1174.
53. Tivol, E.A., Borriello, F., Schweitzer, A.N., Lynch, W.P., Bluestone, J.A., and Sharpe, A.H. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547.
54. Turka, L.A., Linsley, P.S., Lin, H., Brady, W., Leiden, J.M., Wei, R.Q., Gibson, M.L., Zheng, X.G., Myrdal, S., Gordon, D., Bailey, T., Bolling, S.F., and Thompson, C.B. (1992). T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA 89, 11102-11105.
55. Walunas, T.L., Lenschow, D.J., Bakker, C.Y., Linsley, P.S., Freeman, G.J., Green, M., Thompson, C.B., and Bluestone, J.A. (1994). CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413.
56. Waterhouse, P., Penninger, J.M., Timms, E., Wakeham, A., Shahinian, A., Lee, K.P., Thompson, C.B., Griesser, H., and Mak, T. (1995). Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270, 985-988.
57. Wetzler, L.W., Ho, Y., and Reiser, H. (1996). Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and proliferate. J. Exp. Med. 183, 1151-1159.
58. Xu, J.C., Foy, T.M., Laman, J.D., Elliott, E.A., Dunn, J.J., Waldschmidt, T.J., Elsemore, J., Noelle, R.J., and Flavell, R.A. (1994). Mice deficient for CD40 ligand. Immunity 1, 423-431.
59. Yokochi, T., Holly, R.D., and Clark, E.A. (1982). Lymphoblastoid antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid lines, and Burkitt's lymphomas. J. Immunol. 128, 823-827.